PRINCETON, N.J., Nov. 29 /PRNewswire/ -- Next Inning Technology Research (http://www.nextinning.com/), a subscription service focused on semiconductor and technology stocks, announced it has updated outlooks for Catalyst Semiconductor (NASDAQ:CATS), OmniVision Technologies (NASDAQ:OVTI), Semtech (NASDAQ:SMTC), and Advanced Micro Devices (NYSE:AMD).
New subscribers will also receive Next Inning's Q3 State of Tech Report, a $149 value, free when they sign up for a complimentary 21-day trial subscription to Next Inning. In its entirety, Next Inning's Q3 State of Tech report is nearly 100 pages chock-full of charts, tables, and actionable investment commentary: https://www.nextinning.com/subscribe/index.php?refer=prn382 In his earnings previews, Editor Paul McWilliams wrote: "As I've written in the past, one will seldom make money investing in the obvious and, at least from my precarious perch, the fact that CMOS image sensor sales will grow is grossly obvious. But why, you may ask, if that is so obvious, is OmniVision stock trading at a forward price to earnings ratio of only about 12.5:1? The answer to this is that the market now sees OmniVision similarly to how I portrayed the company in the detailed report we published on the image sensor market last February when the stock was trading in the mid to upper $20s..." McWilliams looks at these topics: -- What strategy does McWilliams recommend for OmniVision investors
heading into the company's quarterly report? -- What is McWilliams current outlook for Catalyst? Does he expect the
stock to rally in the coming months? -- Is Semtech trading at an attractive valuation right now? Does
McWilliams see Semtech as a strong investment candidate? -- How might AMD surprise Wall Street over the next three to six months? Founded in September 2002, Next Inning's model portfolio has returned 278% since its inception versus 86% for the Nasdaq.
About Next Inning: Next Inning is a subscription financial newsletter focused on technology stocks. Editor Paul McWilliams is a 20+-year industry veteran.
NOTE: This release was published by Indie Research Advisors, LLC (CRD #131926), a registered investment advisor with the NASD and State of NJ. Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
CONTACT: Marcie Martin, Next Inning Technology Research, +1-888-278-5515 DATASOURCE: Indie Research Advisors, LLC CONTACT: Marcie Martin, Next Inning Technology Research, +1-888-278-5515 Web site: http://www.nextinning.com/
|